Comorbid infections in patients with spondyloarthritis who received modern antirheumatic therapy (preliminary data)
Actuality. Data on the prevalence of comorbid infections (CI) in patients with spondyloarthritis (SpA) are few. Risk factors for CI has not been sufficiently studied.Objective. To evaluate the frequency of comorbid infections in patients with spondyloarthritis treated with biological drugs in the fo...
Saved in:
| Main Authors: | M. M. Baranova, N. V. Muravyeva, B. S. Belov, S. I. Glukhova, T. V. Korotaeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2022-09-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3199 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comorbid infections in patients with spondyloarthritis: frequency, structure and risk factors
by: M. M. Baranova, et al.
Published: (2023-08-01) -
Comorbid infections in spondyloarthritis: a modern view of the problem
by: N. V. Muravyeva, et al.
Published: (2020-11-01) -
Vaccinoprophylaxis of infections and activity of immuno-inflammatory rheumatic diseases: pro et contra
by: B. S. Belov, et al.
Published: (2024-04-01) -
Vaccination in rheumatology: the present and prospects
by: Boris Sergeyevich Belov, et al.
Published: (2012-09-01) -
Comorbid Infections in Rheumatic Diseases
by: B. S. Belov, et al.
Published: (2020-05-01)